ImmunotEGG
Santiago · Founded 2012
About ImmunotEGG
We develop fluorescently labeled antibodies for the diagnostics and life science research industries. Our new low production cost technology is based on the novel combination of fluorescent quantum dot nanoparticles and hen antibodies purified from egg yolk, this competitive advantage will allow antibody technology to colonize the diagnostics industry!
Company Facts
- Founded: 2012
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $40.0K
- Funding stage: Seed
- Last round: Seed (Dec 2013)
- Website: immunotegg.com
Canonical: https://fsome.com/organization/immunotegg-8330902 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.